APOE and cardiovascular disorder: Conversely, inhibition of NF-κB in vascular cells often exhibits therapeutic effects on cardiovascular diseases, such as the amelioration of vascular atherosclerotic lesion in apolipoprotein E (ApoE)-deficient mice (Chiba et al., 2006; Gareus et al., 2008; Mallavia et al., 2013).